MENU
Medical Excellence JAPAN (MEJ) is a general incorporated association, which was established to serve as the central organizational hub to facilitate overseas expansion in the healthcare and medical care sector, based on one of Japan’s growth strategies.
MEJ is an organization that promotes international health cooperation by joint with governments, medical communities, academic organizations encompassing associations of medical sciences , and healthcare industry. MEJ also provides a business development platform in response to the needs of countries that could benefit from excellent medical technology, medical equipment, human resource development, and other healthcare services from Japan.
Name | Medical Excellence JAPAN (MEJ) |
---|---|
Location | Nihonbashi Life Science Building2 #804, 3-11-5 Nihonbashi-honcho, Chuo-ku, Tokyo, 103-0023 Japan |
Tel. | +81-3-6261-3971 |
Establishment | October 2011 |
CEO | Kenji Shibuya |
Executives | List of Executives (PDF) (As of November 11, 2024) |
Activities and projects |
Management of the MEJ Forum A range of projects to establish the foundation for the globalization of Japan’s medical services A range of projects to help organizations globalize their medical services Projects commissioned by governmental agencies MEJ manages committees and the MEJ Forum. It also implements a range of projects including those seeking to establish the foundation for the globalization of Japan’s medical services and those assisting organizations in globalizing their medical services, as well as projects commissioned by governmental agencies. |
Member companies | List of Member Companies (PDF) (as of November 01,2024) |
Transportation
|
Fiscal 2011 | Medical Excellence JAPAN (MEJ) was established with the support of the Japanese Ministry of Economy, Trade and Industry (METI). |
---|---|
Began public relations (PR) activities with a focus on establishing the infrastructure to accept patients from overseas. | |
Fiscal 2012 | Task force mainly composed of medical equipment manufacturers launched by METI for the full-scale operation of MEJ. |
Began inviting companies to join MEJ as its members. | |
Fiscal 2013 | Dr. Shuzo Yamamoto assumed the position of CEO |
Medical device suppliers and others joined MEJ, resulting in the expansion of MEJ’s scope of business activity to include export of medical services (Outbound). | |
Commissioned by the Cabinet Secretariat and METI to undertake a medical globalization project. | |
Conducted a public-private joint mission in Vietnam and India. | |
Fiscal 2014 | Commissioned by METI to undertake the project to accelerate the globalization of Japan’s medical services and began soliciting proposals for the project as the project manager. |
Commissioned by METI to undertake a medical globalization project. | |
Conducted a public-private mission in India, Vietnam, Russia, Myanmar, and Indonesia. | |
Fiscal 2015 | Commissioned by METI to undertake the promotion project to establish medical technologies and service bases. |
Launched the MEJ Forum as a forum to foster exchange and cooperation among medical institutions and medical associations. | |
Began the medical travel assistance company accreditation system based on the guidelines set by the government’s Medical Globalization Task Force.
Selected two companies to be Accredited Medical Travel Assistance Companies (AMTAC). |
|
MEJ and Toshiba Medical Systems Corporation (present Canon Medical Systems Corporation) established the Russia-Japan Cardiac Imaging Training Center in cooperation with the I.M. Sechenov First Moscow State Medical University and A.L. Myasnikov Institute of Clinical Cardiology. | |
Conducted a public-private mission in Vietnam, the Philippines, Myanmar, and Bangladesh. | |
Fiscal 2016 | Commissioned by METI to undertake a promotion project to establish medical technologies and service bases. |
Began the activity to recommend Japanese hospitals that had a record of accepting inbound medical travelers and met certain criteria as “Japan International Hospitals” (tentative name) overseas. | |
Decision made to officially use the name “Japan International Hospitals (JIH)” and 28 hospitals were recommended as JIH. | |
The special website “JAPAN Hospital Search (JHS)” launched and the 28 hospitals recommended as JIH were listed on the website. | |
Held two symposiums as part of the MEJ Forum activities. | |
Conducted a public-private mission in the Philippines, Myanmar, and Saudi Arabia. | |
Fiscal 2017 | Commissioned by METI to undertake a promotion project to establish medical technologies and service bases. |
MEJ and the Japan External Trade Organization (JETRO) signed a memorandum of understanding on a partnership to support medical device/service companies in globalizing their business. | |
Held two symposiums as part of the MEJ Forum activities. | |
An additional 13 hospitals were recommended as Japan International Hospitals (JIH) (Total of 41 hospitals) | |
Added Chinese, Russian, and Japanese languages to the languages available on the “JAPAN Hospital Search (JHS)” website to make it multilingual. | |
Launched an “Inbound” committee with the participation of MEJ member companies and MEJ Forum members and began conducting specific activities under the three sub-committees (one each on accreditation, promotion, and examination of issues). | |
Conducted a public-private mission in Thailand and Saudi Arabia. | |
Fiscal 2018 | Commissioned by METI to undertake a promotion project to establish international healthcare bases. |
The Japanese name of the MEJ Forum, "Forum for Cooperation Regarding the International Expansion of Japanese Medicine (MEJ Forum)"[English translation] has been changed to the "MEJ Forum". | |
2 symposiums of the "MEJ Forum were held | |
An additional 8 hospitals were recommended as Japan International Hospitals (JIH) (Total of 49 hospitals) | |
Fiscal 2019 | Commissioned by METI to undertake a promotion project to establish international healthcare bases. |
Dr. Tatsuya Kondo assumed the position of CEO |